ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Budapest, Budapest

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Diabetic Foot
Overweight
Foot Ulcer

Diabetes trials near Budapest, Budapest, HUN:

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes (DIAGNODE-3)

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Active, not recruiting
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Budapest, Hungary and 59 other locations

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.

Active, not recruiting
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Drug: Maridebart cafraglutide
Drug: Placebo

Phase 3

Amgen
Amgen

Budapest, Hungary and 186 other locations

This study will look at how much cagrilintide helps people with overweight or obesity and type 2 diabetes lower their body weight. Cagrilint...

Enrolling
Type 2 Diabetes
Overweight
Drug: Cagrilintide
Drug: Placebo (matched to Cagrilintide)

Phase 3

Novo Nordisk
Novo Nordisk

Komárom, Hungary and 66 other locations

Phase II study aims to evaluate the efficacy, tolerability, and safety of RO7795081 for glycemic control in adult participants with Type 2 diabetes...

Enrolling
Type 2 Diabetes Mellitus
Drug: Semaglutide
Drug: Placebo

Phase 2

Roche
Roche

Budapest, Hungary and 51 other locations

index of 27 kg/m² or more. People can take part if they have type 2 diabetes and if they are currently being treated only with diet and exer...

Active, not recruiting
Diabetes Mellitus, Type 2
Obesity
Drug: Survodutide
Drug: Placebo

Phase 3

Boehringer Ingelheim
Boehringer Ingelheim

Kistarcsa, Hungary and 145 other locations

This study will look at how much CagriSema lowers blood sugar and body weight in people with type 2 diabetes. CagriSema is a new investigati...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Cagrilintide
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Budapest, Hungary and 164 other locations

This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high ...

Enrolling
Diabetic Retinopathy
Drug: BI 764524
Drug: Aflibercept (Eylea®) - US only

Phase 2

Boehringer Ingelheim
Boehringer Ingelheim

Budapest, Hungary and 89 other locations

in comparison with the active control, ranibizumab, in patients with diabetic macular edema (DME)In the first year, all 3 treatment groups w...

Active, not recruiting
Diabetic Macular Edema (DME)
Drug: EYE103
Drug: Ranibizumab

Phase 2, Phase 3

EyeBiotech

Budapest, Hungary and 182 other locations

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have t...

Enrolling
Diabetes Mellitus, Type 2
Hypertension
Drug: Placebo matching Vicadrostat
Drug: Vicadrostat

Phase 3

Boehringer Ingelheim
Boehringer Ingelheim

Budapest, Hungary and 1159 other locations

The main purpose of this study is to assess the dose-response relationship of maridebart cafraglutide on glucose control compared with placebo.

Active, not recruiting
Type 2 Diabetes Mellitus (T2DM)
Drug: Maridebart Cafraglutide
Drug: Placebo

Phase 2

Amgen
Amgen

Budapest, Hungary and 96 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems